Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now shows a new revision labeled v3.5.0, while the previous revision v3.4.3 is no longer listed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded revision entry v3.4.3 and removed v3.4.2 from the history.SummaryDifference0.1%

- Check50 days agoChange Detected- The record history shows a new revision v3.4.2 added and v3.4.1 removed, indicating a minor update to the page’s revision history. There are no visible changes to study data or page content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page history now shows an addition of Revision: v3.4.1 and removal of Revision: v3.4.0, reflecting a minor update to the record’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedUI updates add a Show glossary option, green and red highlights to indicate additions and deletions, and a Revision: v3.4.0, with No FEAR Act data removal noted (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check79 days agoChange DetectedRevision: v3.3.4 was added to the record history. Revision: v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.